Back to search

France· FR:66807418

GRANOCYTE 13 Millions UI/ml, poudre et solvant pour solution injectable/perfusion en seringue préremplie

A lenograstim product containing lénograstim, registered in France by CHUGAI PHARMA FRANCE, on the national reimbursement list. The same ATC class is registered in 8 of our 19 countries.

Reimbursed in France (Assurance maladie)ATC L03AA10

Checked against Base de données publique des médicaments — BDPM (France) on

Informational only — not a medical device.

SOURCE REGISTER · FRBase de données publique des médicament…normalisedGRANOCYTE 13 Millions UI/ml, poudre e…ATCL03AA10REGISTER NO.FR:66807418PACKS LISTED2CHECKEDSeptember 12, 2026

Where it is registered

Lenograstim is registered in 8 of 19 countries.

Countries holding a registration under ATC L03AA10 (lenograstim), each read from that country’s own register.

  • This record: France, from Base de données publique des médicaments — BDPM (France)
  • 5 of them publish a price we can compare per daily dose

Lenograstim · ATC L03AA10

8 / 19 countries

  • Belgiumprice
  • Finlandprice
  • Franceprice
  • Germany
  • Ireland
  • Spainprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

Base de données publique des médicaments — BDPM (France)
Active substance
LÉNOGRASTIM
Manufacturer
CHUGAI PHARMA FRANCE
Country
France (FR)
ATC code
L03AA10
ATC class
Lenograstim
Defined daily dose
0.35 mg, P
Reimbursed
Yes
Source register
Base de données publique des médicaments — BDPM (France)
Last checked
September 12, 2026

Packs & prices · 2

1 priced
  • cip13
    3400934975677
    1 flacon(s) de poudre en verre - 1 seringue(s) préremplie(s) de 1 ml de solvant en verre avec 2 aiguille(s)
    EUR 39.05
  • cip13
    3400934975738
    5 flacon(s) de poudre en verre - 5 seringue(s) préremplie(s) de 1 ml de solvant en verre avec 2 aiguille(s)

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/715c5934-0e85-464d-86c0-d1c99e24cbcb
GET /v1/drugs/715c5934-0e85-464d-86c0-d1c99e24cbcb?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "cis": "66807418",
  "date_amm": "1996-12-06",
  "type_amm": "Procédure de reconnaissance mutuelle",
  "numero_ue": null,
  "substance": "LÉNOGRASTIM",
  "atc_source": "fr_atc_restore_2026-09-06",
  "statut_amm": "Autorisation active",
  "statut_bdm": null,
  "forme_pharmaceutique": "poudre et  solvant pour solution injectable pour perfusion",
  "voies_administration": "intraveineuse;sous-cutanée",
  "etat_commercialisation": "Commercialisée",
  "surveillance_renforcee": "Non"
}

See everything about lenograstim.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.